In last trading session, Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) saw 1.52 million shares changing hands with its beta currently measuring 0.32. Company’s recent per share price level of $1.44 trading at $0.03 or 2.13% at ring of the bell on the day assigns it a market valuation of $233.00M. That closing price of IRWD’s stock is at a discount of -494.44% from its 52-week high price of $8.56 and is indicating a premium of 8.33% from its 52-week low price of $1.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.17 million shares which gives us an average trading volume of 3.25 million if we extend that period to 3-months.
For Ironwood Pharmaceuticals Inc (IRWD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) trade information
Upright in the green during last session for gaining 2.13%, in the last five days IRWD remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $1.44 price level, adding 4.32% to its value on the day. Ironwood Pharmaceuticals Inc’s shares saw a change of -67.49% in year-to-date performance and have moved -1.37% in past 5-day. Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) showed a performance of -3.36% in past 30-days. Number of shares sold short was 16.25 million shares which calculate 6.49 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 7 to the stock, which implies a rise of 79.43% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 7. It follows that stock’s current price would drop -386.11% in reaching the projected high whereas dropping to the targeted low would mean a loss of -386.11% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -47.49% during past 5 years.
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)’s Major holders
Insiders are in possession of 1.93% of company’s total shares while institution are holding 102.53 percent of that, with stock having share float percentage of 104.55%. Investors also watch the number of corporate investors in a company very closely, which is 102.53% institutions for Ironwood Pharmaceuticals Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at IRWD for having 22.88 million shares of worth $149.16 million. And as of 2024-06-30, it was holding 14.3868 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 21.56 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.6737 of outstanding shares, having a total worth of $140.59 million.
